How To Treat Older And Frail Patients With Cll

How to treat older and frail patients with CLL?

Managing Elderly Patients With CLL

Targeted Oncology

Comprehensive geriatric assessments can aid in selecting treatment for elderly patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

How to treat elderly CLL patients in the light of novel therapies

VJHemOnc – Video Journal of Hematology & HemOnc

Age Impacts Treatment Options for Patients With CLL

Targeted Oncology

The management of elderly patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

CLL-Frail trial: efficacy & safety of acalabrutinib in elderly (≥80y) and/or frail patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

The evolution of treatment for elderly patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Lisaftoclax ramp-up combined with acalabrutinib or rituximab in patients with CLL/SLL

VJHemOnc – Video Journal of Hematology & HemOnc

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

Dr. Ferrajoli on Treatment of Elderly Patients With CLL

What is CLL, and does everyone really needs treatment? | Dr. Jeff Sharman | Oncology Brothers #2023

OncBrothers: Practice-Changing Cancer Discussions

Treating Younger and Older Individuals with Chronic Lymphocytic Leukemia

How to treat eldery CLL patients

VJHemOnc – Video Journal of Hematology & HemOnc

The differences in treating older versus younger CLL patients

VJHemOnc – Video Journal of Hematology & HemOnc

Treatment Options for Older Patients With CLL

Overall survival benefit in elderly patients with CLL treated with first-line ibrutinib

VJHemOnc – Video Journal of Hematology & HemOnc

Optimizing treatment for geriatric patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Venetoclax for the Treatment of Elderly Patients With CLL

Targeted Oncology

Geriatric assessment techniques in CLL

VJHemOnc – Video Journal of Hematology & HemOnc